Boston Scientific admits stent risks

September 7, 2006

The U.S.-based Boston Scientific Corp. has admitted there is an increased risk of blood clots caused by use of its drug-coated cardiac stent.

The company -- the leading stent seller in the nation -- says an analysis of clinical data reveals the increased risk of blood clots months after a stent is implanted, The Wall Street Journal reported, noting the announcement marks the first time any stent maker has acknowledged the heightened risk of side effects from using drug-coated stents.

Stents are small, wire-mesh tubes that are inserted into a blood vessel or other body structure to provide support and keep the structure open. The drugs used to coat some stents are designed to prevent growth of tissue after implantation.

The Journal said stent sales exceed $5 billion annually in a market dominated by Boston Scientific and Johnson & Johnson.

Boston Scientific, which has its headquarters in Natick, Mass., claims recent studies suggest both its Taxus brand of stent and J&J's Cypher stent present similar risks of late-occurring blood clots. J&J company officials, however, told the Journal they see no statistically significant risk of late thrombosis caused by their Cypher stents.

Copyright 2006 by United Press International

Explore further: African-Americans have higher risk for blood clots after receiving drug-coated stent

Related Stories

Model predicts how to build a better stent

January 6, 2009

( -- Researchers have been puzzled in recent years by observations that drug-releasing stents (mesh-like tubes implanted to hold patients' coronary arteries open) can increase the likelihood of blood clots and ...

Promising 3-year data: Saving limbs with drug-eluting stents

March 10, 2009

Attempts to treat critical limb ischemia in peripheral arterial disease (PAD) patients with below-the-knee angioplasty are still thwarted by restenosis (the re-narrowing of the artery at the site of angioplasty or stenting), ...

Recommended for you

NASA's space-station resupply missions to relaunch

November 29, 2015

NASA's commercial space program returns to flight this week as one of its private cargo haulers, Orbital ATK, is to launch its first supply shipment to the International Space Station in more than 13 months.

CERN collides heavy nuclei at new record high energy

November 25, 2015

The world's most powerful accelerator, the 27 km long Large Hadron Collider (LHC) operating at CERN in Geneva established collisions between lead nuclei, this morning, at the highest energies ever. The LHC has been colliding ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.